Xingeyuan Biotechnology Co.
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $160M
Investors
- 17
About Xingeyuan Biotechnology Co.
, trading under the name Singleron, operates as a biotechnology company that focuses on developing molecular diagnostic products and automation equipment for clinical application. The company is mainly involved in the field of single-cell multi-omics analysis in drug development, scientific research and genomics industry. The co founder and CEO Dr. Nan Fang is the PhD in Immunology, University of Wolzburg. At present, the company have more than 400 employees, 24 of whom have PhDs. In July 2021, the company launched tissue dissociator Singleron PythoN. The company self developed products include SCOPE™ single-cell sequencing library construction kits, Matrix® automated single cell processing system, CeleScope™ bioinformatic analysis software, and SynEcoSys® annotation database. Besides, the company provides single-cell transcriptome sequencing, single-cell nuclear transcriptome sequencing, immune receptor sequencing, bio-information analysis services for customer.
Who invested in Xingeyuan Biotechnology Co.
17 investors across 5 rounds
See all investors in Xingeyuan Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xingeyuan Biotechnology Co.
Who invested in Xingeyuan Biotechnology Co.?
Xingeyuan Biotechnology Co. has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xingeyuan Biotechnology Co. raised?
Xingeyuan Biotechnology Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Xingeyuan Biotechnology Co. last raise money?
Xingeyuan Biotechnology Co.'s most recent round on record is a Series B, in Nov 2021.
What does Xingeyuan Biotechnology Co. do?
, trading under the name Singleron, operates as a biotechnology company that focuses on developing molecular diagnostic products and automation equipment for clinical application.
Where is Xingeyuan Biotechnology Co. headquartered?
Xingeyuan Biotechnology Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Xingeyuan Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Xingeyuan Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Xingeyuan Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.